These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 850578)

  • 61. Prognostic effect of isolated paraaortic nodal spread in endometrial cancer.
    Türkmen O; Başaran D; Karalök A; Cömert Kimyon G; Taşçı T; Üreyen I; Tulunay G; Turan T
    J Turk Ger Gynecol Assoc; 2018 Nov; 19(4):201-205. PubMed ID: 29588264
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Operative treatment in stage I endometrial carcinoma with deep myometrial invasion and/or grade 3 tumor surgically limited to the corpus uteri. No recurrence with only primary surgery.
    Chen SS
    Cancer; 1989 May; 63(9):1843-5. PubMed ID: 2702593
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Adenocarcinoma of the uterus.
    Delclos L; Fletcher GH; Gutierrez AG; Rutledge FN
    Am J Roentgenol Radium Ther Nucl Med; 1969 Mar; 105(3):603-8. PubMed ID: 5775018
    [No Abstract]   [Full Text] [Related]  

  • 64. Reliability of frozen section examination in identifying poor prognostic indicators in stage I endometrial adenocarcinoma.
    Malviya VK; Deppe G; Malone JM; Sundareson AS; Lawrence WD
    Gynecol Oncol; 1989 Sep; 34(3):299-304. PubMed ID: 2767520
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Adenocarcinoma corpus et colli: analysis of diagnostic variables.
    Calkins AR; Stehman FB; Sutton GP; Reddy S; Hornback NB; Ehrlich CE
    Int J Radiat Oncol Biol Phys; 1986 Jun; 12(6):911-6. PubMed ID: 3721934
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Absence of prognostic significance, peritoneal dissemination and treatment advantage in endometrial cancer patients with positive peritoneal cytology.
    Konski A; Poulter C; Keys H; Rubin P; Beecham J; Doane K
    Int J Radiat Oncol Biol Phys; 1988 Jan; 14(1):49-55. PubMed ID: 3335462
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Treatment of endometrial cancer in a regional radiation therapy center: analysis of 379 consecutive patients.
    McCabe JB; Sagerman RH
    Cancer; 1979 Mar; 43(3):1052-7. PubMed ID: 427712
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Clinical (stage III) as compared to subclinical intrapelvic extrauterine tumor spread in endometrial carcinoma: a clinical and histopathological study of 175 patients.
    Aalders JG; Abeler V; Kolstad P
    Gynecol Oncol; 1984 Jan; 17(1):64-74. PubMed ID: 6693053
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Prognostic aspects of endometrial carcinoma.
    Svigos JM; Cox LW; Kirkland JA; Harvey ND
    Aust N Z J Obstet Gynaecol; 1978 Nov; 18(4):253-8. PubMed ID: 284770
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Hysterography and diagnostic curettage in carcinoma of the uterine body. An evaluation of diagnostic value and therapeutic implications in stages I and II.
    Johnsson JE
    Acta Radiol Suppl; 1973; 326():1-79. PubMed ID: 4516739
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The current status of surgery for endometrial carcinoma: facts and fantasy.
    Kneale BL
    Aust N Z J Surg; 1979 Jun; 49(3):327-30. PubMed ID: 289372
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Evolution of radiotherapeutic techniques.
    Brady LW; Lewis GC; Antoniades J; Prasasvinichai S; Torpie RJ; Asbell SO; Glassburn JR; Schatanoff D; MacMurray T
    Gynecol Oncol; 1974 Aug; 2(2-3):314-23. PubMed ID: 4457407
    [No Abstract]   [Full Text] [Related]  

  • 73. Are retroperitoneal lymph node metastases a major problem in endometrial adenocarcinoma? Diagnostic and prognostic assessment with lymphography.
    Musumeci R; De Palo G; Conti U; Kenda R; Mangioni C; Belloni C; Marzi M; Bandieramonte G
    Cancer; 1980 Oct; 46(8):1887-92. PubMed ID: 7427892
    [TBL] [Abstract][Full Text] [Related]  

  • 74. A retrospective analysis of 53 patients with pathologic stage II and III endometrial carcinoma.
    De Palo G; Kenda R; Andreola S; Bandieramonte G; Luciani L; Stefanon B
    Tumori; 1982 Aug; 68(4):341-7. PubMed ID: 7147361
    [No Abstract]   [Full Text] [Related]  

  • 75. Architectural (FIGO) grading, nuclear grading, and other prognostic indicators in stage I endometrial adenocarcinoma with identification of high-risk and low-risk groups.
    Mittal KR; Schwartz PE; Barwick KW
    Cancer; 1988 Feb; 61(3):538-45. PubMed ID: 3338021
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Prognosis and treatment of endometrial cancer.
    Berman ML; Ballon SC; Lagasse LD; Watring WG
    Am J Obstet Gynecol; 1980 Mar; 136(5):679-88. PubMed ID: 7355948
    [TBL] [Abstract][Full Text] [Related]  

  • 77. A comparison of the clinical behavior of uterine adenocarcinomas and adenoacanthomas.
    Pokoly T
    Am J Obstet Gynecol; 1970 Dec; 108(7):1080-4. PubMed ID: 5479686
    [No Abstract]   [Full Text] [Related]  

  • 78. Endometrial carcinoma presenting with ascites.
    Morris M; Noumoff J; Beckman EM; Bigelow B
    Gynecol Oncol; 1985 Jun; 21(2):186-95. PubMed ID: 3988131
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Value of several morphologic tumor characteristics for prognosis of cancer of the uterine body].
    Chepik OF; Volkova AT; Bokhman IaV
    Vopr Onkol; 1976; 22(9):34-8. PubMed ID: 1007139
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Vaginal and paraaortic lymph node metastases in carcinoma of the endometrium.
    Leibel SA; Wharam MD
    Int J Radiat Oncol Biol Phys; 1980 Jul; 6(7):893-6. PubMed ID: 7204129
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.